Cargando…

C-reactive Protein Overexpression in the Background Liver of Hepatitis B Virus–Associated Hepatocellular Carcinoma Is a Prognostic Biomarker

BACKGROUND: Chronic hepatitis B virus (HBV) infection is a leading cause of hepatocellular carcinoma (HCC). Peripheral blood C-reactive protein (CRP) concentration and CRP overexpression in HCC cells are proven to be prognostic markers for HCC, but the significance of CRP expression in non-neoplasti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shin, Jin Ho, Yu, Eunsil, Kim, Eun Na, Kim, Chong Jai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society of Pathologists and the Korean Society for Cytopathology 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6166009/ https://www.ncbi.nlm.nih.gov/pubmed/30056637 http://dx.doi.org/10.4132/jptm.2018.07.14

Ejemplares similares

Overexpression of C-reactive Protein as a Poor Prognostic Marker of Resectable Hepatocellular Carcinomas
por: Shin, Jin Ho, et al.
Publicado: (2015)

Shortened Telomere Length in Hepatocellular Carcinomas and Corresponding Background Liver Tissues of Patients Infected with Hepatitis Virus
por: Ohashi, Kazuo, et al.
Publicado: (1996)

Histopathological Causes of Late Liver Allograft Dysfunction: Analysis at a Single Institution
por: Shin, Eun, et al.
Publicado: (2013)

Astrocyte elevated gene-1 overexpression in hepatocellular carcinoma: an independent prognostic factor
por: Jung, Hae Il, et al.
Publicado: (2015)

The Prognostic Role of On-Treatment Liver Stiffness for Hepatocellular Carcinoma Development in Patients with Chronic Hepatitis B
por: Lee, Hye Won, et al.
Publicado: (2021)

Prognostic analysis of hepatocellular carcinoma on the background of liver cirrhosis via contrast-enhanced ultrasound and pathology
por: He, Yukai, et al.
Publicado: (2018)

The effect of chronic viral hepatitis on prognostic value of inflammatory biomarkers in hepatocellular carcinoma
por: Sellers, Cortlandt M., et al.
Publicado: (2021)

Pathological prognostic factors for post-resection survival in patients with hepatocellular carcinoma associated with non-alcoholic fatty liver disease
por: D’Silva, Mizelle, et al.
Publicado: (2021)

Prognostic significance of inflammatory biomarkers in hepatocellular carcinoma following hepatic resection
por: Itoh, S., et al.
Publicado: (2019)

Prognostic value of c-Met overexpression in hepatocellular carcinoma: a meta-analysis and review
por: Kim, Jung Han, et al.
Publicado: (2017)

Dysregulation of Liver Regeneration by Hepatitis B Virus Infection: Impact on Development of Hepatocellular Carcinoma
por: Park, Eun-Sook, et al.
Publicado: (2022)

Development of a transgenic mouse model of hepatocellular carcinoma with a liver fibrosis background
por: Chung, Sook In, et al.
Publicado: (2016)

Cirrhosis, Age, and Liver Stiffness-Based Models Predict Hepatocellular Carcinoma in Asian Patients with Chronic Hepatitis B
por: Lim, Jihye, et al.
Publicado: (2021)

Carcinogenesis on the background of liver fibrosis: Implications for the management of hepatocellular cancer
por: O’Rourke, Joanne Marie, et al.
Publicado: (2018)

Reactivation of Hepatitis B Virus in HBsAg-Negative Patients with Hepatocellular Carcinoma
por: Jang, Jeong Won, et al.
Publicado: (2015)

Role of Ischemic Preconditioning in the Cardioprotective Mechanisms of Monomeric C-Reactive Protein-Deposited Myocardium in a Rat Model
por: Kim, Eun Na, et al.
Publicado: (2021)

Associating liver partition and portal vein ligation for a patient with hepatocellular carcinoma with a background of hepatitis B related fibrotic liver
por: Chia, Nam Hung, et al.
Publicado: (2014)

The Clinicopathological and Prognostic Significance of the Gross Classification of Hepatocellular Carcinoma
por: Lee, Yangkyu, et al.
Publicado: (2018)

Comparison of hepatic and serum lipid signatures in hepatocellular carcinoma patients leads to the discovery of diagnostic and prognostic biomarkers
por: Lu, Yonghai, et al.
Publicado: (2017)

Diagnostic and prognostic biomarkers of Human Leukocyte Antigen complex for hepatitis B virus-related hepatocellular carcinoma
por: Wang, Xiang-Kun, et al.
Publicado: (2019)

NF-Y Overexpression in Liver Hepatocellular Carcinoma (HCC)
por: Bezzecchi, Eugenia, et al.
Publicado: (2020)

Circulating liver cancer stem cells and their stemness-associated MicroRNAs as diagnostic and prognostic biomarkers for viral hepatitis-induced liver cirrhosis and hepatocellular carcinoma
por: Hassan, Marwa, et al.
Publicado: (2022)

Tissue Circular RNA_0004018 and 0003570 as Novel Prognostic Biomarkers for Hepatitis B-Related Hepatocellular Carcinoma
por: Kang, Min-Kyu, et al.
Publicado: (2023)

Development of a nomogram for screening of hepatitis B virus-associated hepatocellular carcinoma
por: Chung, Jung Wha, et al.
Publicado: (2017)

New prognostic biomarkers of mortality in patients undergoing liver transplantation for hepatocellular carcinoma
por: Lorente, Leonardo
Publicado: (2018)

Hepatitis B virus reactivation after radiotherapy for hepatocellular carcinoma and efficacy of antiviral treatment: A multicenter study
por: Jun, Baek Gyu, et al.
Publicado: (2018)

Hepatic abscess mimicking hepatocellular carcinoma in a patient with alcoholic liver disease
por: Kim, Jin Woong, et al.
Publicado: (2013)

Association between hepatic steatosis and the development of hepatocellular carcinoma in patients with chronic hepatitis B
por: Lee, Yun Bin, et al.
Publicado: (2019)

SHP2 is induced by the HBx-NF-κB pathway and contributes to fibrosis during human early hepatocellular carcinoma development
por: Kang, Hyo Jeong, et al.
Publicado: (2017)

Promising Novel Biomarkers for Hepatocellular Carcinoma: Diagnostic and Prognostic Insights
por: Yu, James, et al.
Publicado: (2023)

KIAA1199 overexpression is associated with abnormal expression of EMT markers and is a novel independent prognostic biomarker for hepatocellular carcinoma
por: Jiang, Zhengchen, et al.
Publicado: (2018)

A-kinase anchoring protein 12 is downregulated in human hepatocellular carcinoma and its deficiency in mice aggravates thioacetamide-induced liver injury
por: Lee, Hye Shin, et al.
Publicado: (2018)

Inflammation-Based Prognostic Scores in Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma After Liver Transplantation
por: Ren, Ao, et al.
Publicado: (2020)

Adrenal Cortical Neoplasm with Uncertain Malignant Potential Arising in the Heterotopic Adrenal Cortex in the Liver of a Patient with Beckwith-Wiedemann Syndrome
por: Kim, Eun Na, et al.
Publicado: (2019)

Novel Gene Signatures as Prognostic Biomarkers for Predicting the Recurrence of Hepatocellular Carcinoma
por: Son, Ju A, et al.
Publicado: (2022)

Sarcopenia and blood myokine levels as prognostic biomarkers in patients with liver cirrhosis or hepatocellular carcinoma
por: Oh, Sooyeon, et al.
Publicado: (2020)

Differentially expressed liver exosome-related genes as candidate prognostic biomarkers for hepatocellular carcinoma
por: Zuo, Bangyou, et al.
Publicado: (2022)

Assessment of high-sensitivity C-reactive protein tests for the diagnosis of hepatocellular carcinoma in patients with hepatitis B-associated liver cirrhosis
por: Ma, Li-Na, et al.
Publicado: (2017)

Laparoscopic treatment of hepatic cysts located in the posterosuperior segments of the liver
por: Lee, Doo-Ho, et al.
Publicado: (2014)

Pathological Impact of Hepatitis B Virus Surface Proteins on the Liver Is Associated with the Host Genetic Background
por: Churin, Yuri, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_rl6ovkduna8bh8hd9p580ivgml